Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Straub

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|March 18, 2023
BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α<sub>2B</sub> AntagonistDaniel Meibom, Jutta Meyer, Clemens-Jeremias von Buehler, et al.
IEEE Computer Graphics and Applications|August 4, 2020
2019 IEEE Scientific Visualization Contest Winner: Visual Analysis of Structure Formation in Cosmic EvolutionKarsten Schatz, Christoph Muller, Patrick Gralka, et al.
Chemmedchem|March 6, 2009
Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertensionJoachim Mittendorf, Stefan Weigand, Cristina Alonso-Alija, et al.
Journal of Medicinal Chemistry|November 14, 2024
Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus ResolutionChantal Fürstner, Jens Ackerstaff, Heinrich Meier, et al.
Journal of Medicinal Chemistry|October 28, 2024
Discovery of BAY 2413555, First Selective Positive Allosteric Modulator of the M2 Receptor to Restore Cardiac Autonomic BalanceAlexandros Vakalopoulos, Daniel Basting, Markus Brechmann, et al.
Journal of Medicinal Chemistry|May 31, 2017
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart FailureMarkus Follmann, Jens Ackerstaff, Gorden Redlich, et al.
Journal of Medicinal Chemistry|April 11, 2023
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-<i>a</i>]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant HypertensionAlexandros Vakalopoulos, Frank Wunder, Ingo V Hartung, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|March 18, 2023
BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α<sub>2B</sub> AntagonistDaniel Meibom, Jutta Meyer, Clemens-Jeremias von Buehler, et al.
IEEE Computer Graphics and Applications|August 4, 2020
2019 IEEE Scientific Visualization Contest Winner: Visual Analysis of Structure Formation in Cosmic EvolutionKarsten Schatz, Christoph Muller, Patrick Gralka, et al.
Chemmedchem|March 6, 2009
Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertensionJoachim Mittendorf, Stefan Weigand, Cristina Alonso-Alija, et al.
Journal of Medicinal Chemistry|November 14, 2024
Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus ResolutionChantal Fürstner, Jens Ackerstaff, Heinrich Meier, et al.
Journal of Medicinal Chemistry|October 28, 2024
Discovery of BAY 2413555, First Selective Positive Allosteric Modulator of the M2 Receptor to Restore Cardiac Autonomic BalanceAlexandros Vakalopoulos, Daniel Basting, Markus Brechmann, et al.
Journal of Medicinal Chemistry|May 31, 2017
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart FailureMarkus Follmann, Jens Ackerstaff, Gorden Redlich, et al.
Journal of Medicinal Chemistry|April 11, 2023
New Generation of sGC Stimulators: Discovery of Imidazo[1,2-<i>a</i>]pyridine Carboxamide BAY 1165747 (BAY-747), a Long-Acting Soluble Guanylate Cyclase Stimulator for the Treatment of Resistant HypertensionAlexandros Vakalopoulos, Frank Wunder, Ingo V Hartung, et al.
Pageof 2